Walter H. Moos's most recent trade in Rigel Pharmaceuticals was a trade of 3,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rigel Pharmaceuticals | Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 3,000 | 3,000 | - | - | Stock Option (Right to Buy) | |
| Rigel Pharmaceuticals | Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 2,500 | 12,722 (0%) | 0% | 0 | Common Stock | |
| Rigel Pharmaceuticals | Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Rigel Pharmaceuticals | Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2024 | 25,000 | 102,222 (0%) | 0% | 0 | Common Stock | |
| Rigel Pharmaceuticals | Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Rigel Pharmaceuticals | Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 25,000 | 77,222 (0%) | 0% | 0 | Common Stock | |
| Rigel Pharmaceuticals | Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Rigel Pharmaceuticals | Walter H. Moos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 25,000 | 52,222 (0%) | 0% | 0 | Common Stock |